ID   HeLa-P4
AC   CVCL_E8AR
SY   HeLa P4; P4; HeLa-LTR-lacZ clone Z24 CD4 clone P4
RX   PubMed=7520946;
CC   Population: African American.
CC   Characteristics: Expression of CD4 is under the control of a mouse PGK promoter (PubMed=7520946).
CC   Characteristics: Transfected with a construct pMA175 containing the HIV-1 BRU LTR that allows expression of lacZ when Tat is present (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8AP ! HeLa-LTR-lacZ clone Z24
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=7520946; DOI=10.1006/jmbi.1994.1542;
RA   Charneau P., Mirambeau G., Roux P., Paulous S., Buc H., Clavel F.;
RT   "HIV-1 reverse transcription. A termination step at the center of the
RT   genome.";
RL   J. Mol. Biol. 241:651-662(1994).
//